Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Bill Haddad

1664 posts
Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • News

HF Foods Announces Receipt Of Additional Non-Compliance Letter From Nasdaq

By Bill Haddad
August 17, 9:04 AM
  LAS VEGAS, Aug. 17, 2022 (GLOBE NEWSWIRE) -- HF Foods Group Inc. (NASDAQ:HFFG), a leading food distributor to Asian restaurants across the United States (“HF Foods” or the “Company”),

HFFG

Read More
1 minute read
  • FDA
  • News

Omeros Corporation Receives Interim Response From FDA On Formal Dispute Resolution Request For Narsoplimab

By Bill Haddad
August 17, 8:41 AM
Omeros Corporation (NASDAQ:OMER) today announced that the United States Food and Drug Administration (FDA) provided an interim response to the company’s formal dispute resolution request submitted to the Agency in

OMER

Read More
2 minute read
  • General

SRM Entertainment Announces Licensing Agreement with Toonz Media Group And Zoonicorn LLC For Pre-School Brand Zoonicorn

By Bill Haddad
August 17, 8:32 AM
New Zoonicorn Branded Consumer Products From SRM Entertainment to Be Available Beginning Fall, 2022 JUPITER, FL / ACCESSWIRE / August 17, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced that its SRM

JUPW

Read More
2 minute read
  • Biotech
  • General

Can-Fite Announces Piclidenoson Is Set To Enter Clinical Trial For Treatment Of Osteoarthritis In Dogs Efficacy Trial To Commence And Financially Covered By Vetbiolix

By Bill Haddad
August 17, 7:27 AM
Safety study successfully completed; efficacy trial to commence and financially covered by Vetbiolix Canine osteoarthritis market is projected to reach $3 billion by 2028 PETACH TIKVA, Israel--(BUSINESS WIRE)--

CANF

Read More
1 minute read
  • General
  • Health Care

Israeli Ministry Of Health Approves National Coverage For CytoSorb

By Bill Haddad
August 17, 7:22 AM
PRINCETON, N.J., Aug. 17, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via

CTSO

Read More
1 minute read
  • Earnings
  • News

Rada Electronics Industri Q2 EPS $(0.09) Down From $0.20 YoY, Sales $23.06M Miss $29.13M Estimate

By Bill Haddad
August 17, 7:14 AM
Rada Electronics Industri (NASDAQ:RADA) reported quarterly losses of $(0.09) per share. This is a 145 percent decrease over earnings of $0.20 per share from the same period last year. The company reported quarterly

RADA

Read More
2 minute read
  • Biotech
  • General

ICL And Lavie Bio Enter Collaboration To Develop Novel Bio-Stimulant Products; ICL To Invest $10M In Lavie Bio

By Bill Haddad
August 16, 4:31 PM
ICL to invest $10 million in Lavie Bio ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, and Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), a leading computational biology company focused

EVGN

Read More
2 minute read
  • Biotech
  • General

I-Mab And AbbVie Entered Amendment To Original License And Collaboration Agreement; Parties Will Continue To Collaborate On Anti-CD47 Antibody Program, I-Mab Eligible to Receive Up To $1.295B Milestones

By Bill Haddad
August 16, 4:26 PM
I-Mab (the “Company”) (NASDAQ:IMAB) today announced that the Company and AbbVie Global Enterprises Ltd. (as assignee of AbbVie Ireland Unlimited Company) (“AbbVie”) have entered into an amendment

ABBV

Read More
2 minute read
  • M&A

LHC Group To Acquire Three Rivers Home Health; Expects Annualized Revenue From Purchase Of ~$12M

By Bill Haddad
August 16, 4:17 PM
Transaction expands services across 36 counties LAFAYETTE, La., Aug. 16, 2022 /PRNewswire/ -- LHC Group (NASDAQ:LHCG) today announced an agreement to purchase Three Rivers Home Health, a provider headquartered

LHCG

Read More
1 minute read
  • Earnings
  • News

Agilent Technologies Q3 Adj. EPS $1.34 Beats $1.18 Estimate, Sales $1.72B Beat $1.61B Estimate; Shares Spike

By Bill Haddad
August 16, 4:05 PM
Agilent Technologies (NYSE:A) reported quarterly earnings of $1.34 per share which beat the analyst consensus estimate of $1.18 by 13.56 percent. This is a 21.82 percent increase over earnings of $1.10 per share from the same period last year.

A

Posts pagination

Previous 1 … 100 101 102 … 167 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service